$0.0782
0.0012[1.56%]
At close: Apr 26
$0.0782
0[0.00%]
After Hours: 7:01PM EDT
NovaBay Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of NovaBay Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | PM | NBY | Q1 | -$0.85 | -$0.20 | — | — | $3.12M | $4.00M | — | — | Get Alert |
03/26/2024 | PM | NBY | Q4 | -$1.47 | -$0.30 | -$0.21 | 30.00% | $3.64M | $3.40M | $3.73M | 9.62% | Get Alert |
11/09/2023 | PM | NBY | Q3 | -$3.50 | -$0.40 | -$0.37 | 7.50% | $3.83M | $3.55M | $3.27M | -8.03% | Get Alert |
08/10/2023 | PM | NBY | Q2 | -$1.40 | -$0.55 | -$1.27 | -130.91% | $3.04M | $3.67M | $4.61M | 25.61% | Get Alert |
05/11/2023 | PM | NBY | Q1 | -$1.75 | -$0.91 | -$0.85 | 6.59% | $3.27M | $3.20M | $3.12M | -2.37% | Get Alert |
03/30/2023 | PM | NBY | Q4 | -$4.20 | -$0.17 | -$1.47 | -764.71% | $2.64M | $5.10M | $3.64M | -28.57% | Get Alert |
11/14/2022 | PM | NBY | Q3 | -$1.75 | -$1.05 | -$3.50 | -233.33% | $1.84M | $3.75M | $3.83M | 2.03% | Get Alert |
08/11/2022 | PM | NBY | Q2 | -$1.40 | -$1.05 | -$1.40 | -33.33% | $2.13M | $3.51M | $3.04M | -13.25% | Get Alert |
05/12/2022 | PM | NBY | Q1 | -$1.40 | -$1.05 | -$1.75 | -66.67% | $1.81M | $3.26M | $2.63M | -19.36% | Get Alert |
03/29/2022 | PM | NBY | Q4 | -$1.40 | -$1.75 | -$4.20 | -140.00% | $1.89M | $3.34M | $2.64M | -21.08% | Get Alert |
11/11/2021 | PM | NBY | Q3 | -$2.80 | -$1.05 | -$1.75 | -66.67% | $2.17M | $3.44M | $1.84M | -46.51% | Get Alert |
08/12/2021 | PM | NBY | Q2 | -$5.25 | -$1.40 | -$1.40 | 0.00% | $3.98M | — | $2.13M | — | Get Alert |
05/06/2021 | PM | NBY | Q1 | -$2.10 | -$1.40 | -$1.40 | 0.00% | $1.89M | $2.34M | $1.81M | -22.78% | Get Alert |
03/25/2021 | PM | NBY | Q4 | -$4.55 | -$1.40 | -$1.40 | 0.00% | $1.70M | $2.48M | $1.89M | -23.87% | Get Alert |
11/12/2020 | PM | NBY | Q3 | -$0.70 | -$1.40 | -$2.80 | -100.00% | $1.61M | $2.52M | $2.17M | -13.89% | Get Alert |
08/06/2020 | PM | NBY | Q2 | -$4.90 | -$1.75 | -$5.25 | -200.00% | $1.79M | $2.85M | $3.98M | 39.79% | Get Alert |
05/07/2020 | PM | NBY | Q1 | -$9.80 | -$2.45 | -$2.10 | 14.29% | $1.49M | $2.09M | $1.89M | -9.47% | Get Alert |
03/26/2020 | PM | NBY | Q4 | -$2.45 | -$2.45 | -$4.55 | -85.71% | $3.63M | $2.07M | $1.70M | -17.68% | Get Alert |
11/07/2019 | PM | NBY | Q3 | -$3.85 | -$2.80 | -$0.70 | 75.00% | $3.14M | $2.05M | $1.61M | -21.22% | Get Alert |
NovaBay Pharmaceuticals (NBY) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on March 26, 2024 for Q4.
The Actual EPS was $-0.21, which beat the estimate of $-0.30.
The Actual Revenue was $3.7M, which beat the estimate of $3.4M.
Browse earnings estimates, EPS, and revenue on all stocks.